Table 3 Regimen, spectrum and type of infection
|  | Cases with infections | Number of infectious episodes | Focus of infection | Opportunistic infections | Identified pathogen | Number of CTC grade 3 + 4 infections* |
|---|---|---|---|---|---|---|
Rituximab monotherapy (n = 23) | 4 | 4 | Pneumonia (n = 1) | 2 | none (n = 2) | 3 |
viral (n = 2) | ||||||
Opp. Inf. (n = 2) | ||||||
Bronchitis (n = 1) | ||||||
R-CHOP/R-CHOEP (n = 88) | 53 | 80 | UTI (n = 12) | 15 | none (n = 47) | 66 |
bacterial (n = 17) | ||||||
URTI (n = 11) | ||||||
Opp. inf. (n = 12) | viral (n = 15) | |||||
Opp. Pneumonia (n =5) | fungal (n = 3) | |||||
Bronchitis (n = 5) |  |  | ||||
FUO (n = 22) |  |  |  | |||
Sepsis (n = 2) |  |  |  | |||
R-FC/R-FCM (n = 8) | 6 | 9 | Bronchitis (n = 3) | 2 | none (n = 4) | 4 |
bacterial (n = 3) | ||||||
OppInf (n = 2) | ||||||
viral (n = 2) | ||||||
UTI (n = 1) | ||||||
FUO (n = 2) | ||||||
Sepsis (n = 1) | ||||||
R-GMALL/R-DHAP (n = 9) | 7 | 19 | UTI (n = 2) | 2 | none (n = 12) | 16 |
bacterial (n = 5) | ||||||
Pneumonia (n = 2) | ||||||
fungal (n = 2) | ||||||
FUO (n = 8) | ||||||
Sepsis (n = 4) | ||||||
URTI (n = 1) | ||||||
Opp Pneumonia (n = 1) | ||||||
Sinusitis (n = 1) | ||||||
R-Gemcitabine (n = 1) | 1 | 1 | Pneumonia (n = 1) | none | 0 | 1 |
R-IMVP16 (n = 2) | 2 | 3 | FUO (n = 1) | 1 | none (n = 2) | 3 |
viral (n = 1) | ||||||
URTI (n = 1) | ||||||
OppInf (n = 1) | ||||||
R-Bendamustine (n = 4) | 1 | 3 | Pneumonia (n = 1) | None | none (n = 1) | 3 |
Sepsis (n = 1) | bacterial (n = 2) | |||||
UTI (n = 1) |  |  | ||||
R-Other (n = 6) | 6 | 19 | FUO (n = 4) | 1 | none (n = 13) | 19 |
Norovirus (n = 1) | viral (n = 1) | |||||
Diarrhea (n = 3) | bacterial (n = 4) | |||||
Pneumonia (n = 4) | fungal (n = 1) | |||||
Sepsis (n = 3) | ||||||
Bronchitis (n = 1) | ||||||
URTI (n = 1) | ||||||
Sinusitis (n = 1) | ||||||
| Â | Opp. Inf. (n =1) | Â | ||||